Your browser doesn't support javascript.
loading
Self-Reported Functional Vision in USH2A-Associated Retinal Degeneration as Measured by the Michigan Retinal Degeneration Questionnaire.
Parekh, Bela; Duncan, Jacque L; Samarakoon, Lassana; Melia, Michele; Abalem, Maria Fernanda; Andrews, Chris A; Audo, Isabelle; Ayala, Allison R; Bradley, Chris; Cheetham, Janet K; Dagnelie, Gislin; Durham, Todd A; Huckfeldt, Rachel M; Lacy, Gabrielle D; Malbin, Brett; Michaelides, Michel; Musch, David C; Peck-Dimit, Nicholas; Stingl, Katarina; Weng, Christina Y; Zmejkoski, Alex Z; Jayasundera, K Thiran.
Afiliación
  • Parekh B; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States.
  • Duncan JL; University of Michigan, Medical School, Ann Arbor, Michigan, United States.
  • Samarakoon L; University of California, San Francisco, San Francisco, California, United States.
  • Melia M; Jaeb Center for Health Research, Tampa, Florida, United States.
  • Abalem MF; Jaeb Center for Health Research, Tampa, Florida, United States.
  • Andrews CA; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States.
  • Audo I; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States.
  • Ayala AR; Institut de la Vision, Sorbonne Université, INSERM, CNRS, Paris, France.
  • Bradley C; Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Centre de Référence Maladies Rares REFERET and INSERM-DGOS CIC1423, Paris, France.
  • Cheetham JK; Jaeb Center for Health Research, Tampa, Florida, United States.
  • Dagnelie G; Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, United States.
  • Durham TA; Foundation Fighting Blindness, Columbia, Maryland, United States.
  • Huckfeldt RM; Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, United States.
  • Lacy GD; Foundation Fighting Blindness, Columbia, Maryland, United States.
  • Malbin B; Massachusetts Eye and Ear Institute, Boston, Massachusetts, United States.
  • Michaelides M; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States.
  • Musch DC; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States.
  • Peck-Dimit N; Department of Ophthalmology, Kresge Eye Institute, Detroit, Michigan, United States.
  • Stingl K; Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, United Kingdom.
  • Weng CY; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States.
  • Zmejkoski AZ; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, United States.
  • Jayasundera KT; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States.
Invest Ophthalmol Vis Sci ; 65(6): 5, 2024 Jun 03.
Article en En | MEDLINE | ID: mdl-38833260
ABSTRACT

Purpose:

The purpose of this study was to evaluate self-reported functional vision (FV) and the impact of vision loss in patients with USH2A-associated retinal degeneration using a patient-reported outcome (PRO) measure, the Michigan Retinal Degeneration Questionnaire (MRDQ), to correlate MRDQ scores with well-established visual function measurements.

Design:

An observational cross-sectional study (n = 93) of participants who had Usher Syndrome Type 2 (USH2, n = 55) or autosomal recessive non-syndromic retinitis pigmentosa (ARRP; n = 38) associated with biallelic variants in the USH2A gene.

Methods:

The study protocol was approved by all ethics boards and informed consent was obtained from each participant. Participants completed the MRDQ at the 48-month study follow-up visit. Disease duration was self-reported by participants. One-way ANOVA was used to compare subgroups (clinical diagnosis, age, disease duration, and full-field stimulus threshold [FST] Blue-Red mediation) on mean scores per domain. Spearman correlation coefficients were used to assess associations between MRDQ domains and visual/retinal function assessments.

Results:

Of the study sample, 58% were female participants and the median disease duration was 13 years. MRDQ domains were sensitive to differences between subgroups of clinical diagnosis, age, disease duration, and FST Blue-Red mediation. MRDQ domains correlated with static perimetry, microperimetry, full-field stimulus testing, and best-corrected visual acuity (BCVA).

Conclusions:

Self-reported FV measured by the MRDQ, when applied to USH2 and ARRP participants, had good distributional characteristics and correlated well with visual function tests. MRDQ adds a new dimension of understanding on vision-related functioning and establishes this PRO tool as an informative measure in evaluating USH2A outcomes.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Agudeza Visual / Proteínas de la Matriz Extracelular / Síndromes de Usher / Autoinforme Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest Ophthalmol Vis Sci Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Agudeza Visual / Proteínas de la Matriz Extracelular / Síndromes de Usher / Autoinforme Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest Ophthalmol Vis Sci Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos